Shares of GeneNews Ltd (TSE:GEN) reached a new 52-week low on Monday . The stock traded as low as C$0.04 and last traded at C$0.04, with a volume of 95500 shares traded. The stock had previously closed at C$0.04.
GeneNews (TSE:GEN) last posted its quarterly earnings results on Wednesday, August 15th. The company reported C($0.03) earnings per share for the quarter. The business had revenue of C$0.02 million for the quarter.
ILLEGAL ACTIVITY NOTICE: “GeneNews (GEN) Reaches New 52-Week Low at $0.04” was reported by Week Herald and is owned by of Week Herald. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://weekherald.com/2018/11/07/genenews-gen-reaches-new-52-week-low-at-0-04.html.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Story: Technical Analysis
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.